IOVS Am. J. Clin. Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:2917-2923.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-1253

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quaranta, L.
Right arrow Articles by Gandolfo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quaranta, L.
Right arrow Articles by Gandolfo, E.

Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma

Luciano Quaranta, Federico Gandolfo, Raffaele Turano, Federico Rovida, Teodoro Pizzolante, Andrea Musig, and Enrico Gandolfo

From the Clinica Oculistica, Università degli Studi di Brescia, Brescia, Italy.

PURPOSE. To compare the short-term effects of timolol 0.5%, brimonidine 0.2%, dorzolamide 2%, and latanoprost 0.005% on intraocular pressure (IOP), blood pressure (BP), and diastolic ocular perfusion pressure (DOPP), calculated as the difference between the diastolic blood pressure (DBP) and IOP.

METHODS. According to a 4 x 4 Latin squares design for repeated measures, 27 untreated patients and patients with newly diagnosed primary open-angle glaucoma (POAG) were treated with timolol 0.5% at 8 AM and 8 PM; brimonidine 0.2% at 8 AM and 8 PM; dorzolamide 2% at 8 AM, 2 PM, and 8 PM; and latanoprost 0.005% at 8 PM. The duration of each treatment course was 6-weeks, with a 4-week washout between each treatment. IOP and BP were measured at baseline and at the end of each treatment period. IOP was measured every 2 hours throughout a 24-hour period. Sitting IOP was measured from 8 AM to 10 PM by Goldmann applanation tonometry. Supine IOP was assessed from 12 to 6 AM by means of a handheld electronic tonometer (TonoPen XL; Mentor, Norwell, MA). BP monitoring was performed by means of an automated portable device (TM-2430; A & D Co., Saitama, Japan).

RESULTS. All the drugs tested decreased the IOP significantly at all time points in comparison with baseline pressure. The mean 24-hour IOP after latanoprost administration (16.62 ± 0.98 mm Hg) was significantly lower than that after timolol, brimonidine, or dorzolamide (P = 0.0001). During the 24-hour period, brimonidine induced a significant decrease in systolic BP (SBP) and DBP at all time points when compared with baseline measurements and with those after administration of the other drugs (P < 0.0001). Timolol caused a significant decrease in DBP and SBP at all the 24-hour time points when compared with the baseline and with the dorzolamide- and latanoprost-induced changes (P < 0.0001). The mean 24-hour DOPPs were 50.7 ± 5.9 mm Hg at baseline, 53 ± 5.5 mm Hg with timolol, 46.2 ± 5.4 mm Hg with brimonidine, 55.9 ± 4.6 mm Hg with dorzolamide, and 56.4 ± 4.9 mm Hg with latanoprost. Brimonidine induced a significant decrease in the mean 24-hour DOPP compared with that at baseline (P < 0.0001), whereas dorzolamide and latanoprost induced a significant increase (P < 0.0001).

CONCLUSIONS. Latanoprost seemed to induce a uniform reduction in IOP during the 24-hour period, although timolol was as effective as latanoprost during the daytime, and dorzolamide are as effective as latanoprost at night. SBP and DBP were significantly decreased by either timolol or brimonidine. In this study of patients with newly diagnosed POAG, only dorzolamide and latanoprost significantly increased mean 24-hour DOPP.





This article has been cited by other articles:


Home page
IOVSHome page
L. Quaranta, S. Miglior, I. Floriani, T. Pizzolante, and A. G. P. Konstas
Effects of the Timolol-Dorzolamide Fixed Combination and Latanoprost on Circadian Diastolic Ocular Perfusion Pressure in Glaucoma
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4226 - 4231.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. Hong, S. Y. Kang, K. T. Ma, G. J. Seong, and C. Y. Kim
Latent Asymmetric Intraocular Pressure as a Predictor of Visual Field Defects
Arch Ophthalmol, September 1, 2008; 126(9): 1211 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
L Quaranta, T Pizzolante, I Riva, A-B Haidich, A G P Konstas, and W C Stewart
Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma
Br. J. Ophthalmol., September 1, 2008; 92(9): 1227 - 1231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology